Invasive pulmonary aspergillosis digital illustration

Invasive pulmonary aspergillosis Save


ICD-10 code: B44.0

Disease category: B44: Aspergillosis

Invasive Pulmonary Aspergillosis: What You Need to Know

Invasive Pulmonary Aspergillosis (IPA) is a serious fungal infection that primarily affects individuals with compromised immune systems. It is caused by the fungus Aspergillus, which is commonly found in the environment. However, in individuals with weakened immune systems, Aspergillus can invade the lungs and cause serious complications.

IPA is commonly seen in individuals undergoing chemotherapy, bone marrow or hematopoietic stem cell transplantation, and those with HIV/AIDS. It can also occur in individuals with chronic obstructive pulmonary disease (COPD), cystic fibrosis, and those on long-term corticosteroid therapy.

The symptoms of IPA can be non-specific and include fever, cough, shortness of breath, and chest pain. In some cases, IPA can progress rapidly and lead to respiratory failure, making early diagnosis and treatment essential.

  1. Risk Factors: Individuals with compromised immune systems are at the highest risk for IPA. This includes patients undergoing chemotherapy, bone marrow or hematopoietic stem cell transplantation, and those with HIV/AIDS. Other risk factors include COPD, cystic fibrosis, and long-term corticosteroid therapy.
  2. Diagnosis: Diagnosis of IPA can be challenging as the symptoms can be non-specific. Chest imaging, such as CT scans, can show characteristic lesions in the lungs. A definitive diagnosis is made by performing a biopsy of the lung tissue or bronchoalveolar lavage.
  3. Treatment: The treatment of IPA often involves antifungal medications. However, the choice of medication and duration of treatment depend on the severity of the infection, the underlying medical condition, and the patient's response to treatment.

Overall, IPA is a serious fungal infection that primarily affects individuals with weakened immune systems. Early diagnosis and treatment are essential to prevent complications and improve outcomes. If you have any concerns about your risk for IPA or are experiencing symptoms, it is important to speak with your healthcare provider.

Treatment of Invasive pulmonary aspergillosis:

Treatment Options for Invasive Pulmonary Aspergillosis

Invasive pulmonary aspergillosis (IPA) is a severe and potentially fatal condition caused by the fungus Aspergillus. The condition occurs mainly in immunocompromised patients, such as those undergoing chemotherapy or organ transplantation.

Timely and appropriate treatment of IPA is crucial for improving patient outcomes...

To see full information about treatment please Sign up or Log in